Anavex Life Sciences Corp (AVXL)

[tredenwater2]

Benefits to Stakeholders

Reduced operational risks and costs in employing EEG/ERP biomarkers in therapeutic trials
Increased statistical power of EEG/ERP biomarkers to help minimize trial size and cost • Streamlined regulatory process for trials leveraging the EEG/ERP biomarkers
Demonstrated expertise and validated methods in implementing ERP biomarkers for pharma trials by member CROs and study sites
Correlations to standard psychometric testing instruments

Correct me if Im wrong but we have been benefitting from and moreover DOING all these examples already in our trials, BY OURSELVES! So question, why do we need to open up our science and PM trial design to this group...especially sitting at a suppressed 150 million market cap, for free? Seems to me like this is valuable information and dont get me wrong here, the patient comes first but from what I have seen these guys know nothing a out these new trial designs.

We need the Market cap to grow proportionate to our science before we engage more consortiums.

Tred